SCHEMBL2365656

SCHEMBL2365656

O=C(N[C@H]1C2CC3CC(C2)CC1(O)C3)c1cccc(Sc2ccc(Cl)cn2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.39
BRAF P15056 2/20 0.38
KDR P35968 2/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 2/20 0.37
PKM P14618 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GRM5 P41594 4/20 0.36
SERPINE1 P05121 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD11B1 P28845 4/20 0.35
S1PR2 O95136 2/20 0.35
S1PR4 O95977 2/20 0.35
S1PR3 Q99500 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2365636 0.85 HSD11B1 (0.48) HSD11B1
SCHEMBL2365755 0.80 PPARG (0.41) P2RX7NPC1PKMMEN1KMT2A
SCHEMBL2365727 0.80 P2RX7 (0.37) P2RX7NPC1RAB9ATSHRALDH1A1
SCHEMBL13366174 0.79 BRAF (0.37) BRAFKDRNPC1RAB9ATSHR
SCHEMBL2365635 0.76 IP6K1 (0.43) P2RX7NPC1TSHRSMN1; SMN2MEN1
SCHEMBL13366022 0.73 BRAF (0.61) BRAFKDRNPC1RAB9ATSHR
SCHEMBL2365672 0.73 HPGD (0.51) BRAFKDRALDH1A1MEN1KMT2A
SCHEMBL1675961 0.73 FAAH (0.55) P2RX7MEN1KMT2ATDP1HSD11B1
SCHEMBL2365633 0.69 BRAF (0.47) BRAFKDRNPC1RAB9AALDH1A1
SCHEMBL2365642 0.67 FAAH (0.52) TDP1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2362730-A1 ADAMANTYL BENZAMIDE COMPOUNDS High Point Pharmaceuticals, LLC (US) 2011-09-07 EP disclosed
WO-2010059618-A1 ADAMANTYL BENZAMIDE COMPOUNDS HIGH POINT PHARMACEUTICALS, LLC (US) 2010-05-27 WO disclosed